未登录

S

Shih-Ching Chang

Taipei Veterans General Hospital

H指数:44

被引数:5,491

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Influence of Neoadjuvant Chemotherapy Cycles on Surgical Complications in Metastatic Colon Cancer

新辅助化疗周期对转移性结肠癌手术并发症的影响

The American Journal of Surgery

IF0

2025-11-180

PRE

Taiwan society of colon and rectal surgeons’ consensus on the management of hemorrhoidal disease

台湾结直肠外科医师学会关于痔病的治疗共识

International Journal of Colorectal Disease

IF2.3

2025-10-300

OA

Early- vs. late-onset colon cancer: clinicopathological insights and survival outcomes in an East Asian cohort

早发型与晚发型结直肠癌：东亚队列的临床病理学见解及生存结局

International Journal of Colorectal Disease

IF2.3

2025-10-090

OA

Prognostic impact of metastatic sites and its metastasectomy in colorectal cancer: a retrospective analysis from a single institution

结直肠癌中转移部位及其转移灶切除术的预后影响：一项单中心回顾性分析

International Journal of Colorectal Disease

IF2.3

2025-07-020

OAAI

Endoscopic submucosal dissection as an alternative management for huge colon lipoma with acute intussusception

内镜下黏膜下剥离术作为巨大结肠脂肪瘤伴急性肠套叠的替代治疗方法

IF12.8

2025-05-220

OA

Protective loop ileostomy or colostomy? A risk evaluation of all common complications

ANNALS OF COLOPROCTOLOGY

IF2.1

2024-12-315

OAAI

Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic Disability

CLINICAL COLORECTAL CANCER

IF3.2

2023-09-010

OAAI

Modeling the survival of colorectal cancer patients based on colonoscopic features in a feature ensemble vision transformer

COMPUTERIZED MEDICAL IMAGING AND GRAPHICS

IF4.9

2023-07-0119

PRE

Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study

IF5

2023-06-300

OAAI

The clinical experience of the prognosis in opposite CEA and image change after therapy in stage IV colorectal cancer

SCIENTIFIC REPORTS

IF3.9

2022-11-225

OAAI

The Negative Prognostic Impact of Lymph Node Skip Metastasis in Stage III Colon Cancer With pN1 Disease: A Single-Center and Retrospective Cohort Study

DISEASES OF THE COLON & RECTUM

IF3.7

2022-10-263

OAAI

Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients

患者来源的类器官可作为晚期结直肠癌患者个性化化疗的平台

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-0113

OAAI

A Long-Term and Large-Scale Real-World Study in Taiwan: Efficacy of Target Therapy in Stage IV Colorectal Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-03-176

OAAI

Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway (vol 11, 12590, 2021)

SCIENTIFIC REPORTS

IF3.9

2021-08-020

OAAI

Preference criteria for regorafenib in treating refractory metastatic colorectal cancer are the small tumor burden, slow growth and poor/scanty spread

SCIENTIFIC REPORTS

IF3.9

2021-07-284

OAAI

The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon

BRITISH JOURNAL OF CANCER

IF6.8

2021-06-2915

OAAI

Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway

SCIENTIFIC REPORTS

IF3.9

2021-06-1518

OAAI

Eps15 Homology Domain-Containing Protein 3 Hypermethylation as a Prognostic and Predictive Marker for Colorectal Cancer

IF3.9

2021-04-223

OAAI

Clinicopathological and Molecular Features of Colorectal Cancer Patients With Mucinous and Non-Mucinous Adenocarcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-0214

OAAI

Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction

CLINICAL EPIGENETICS

IF4.4

2020-05-1217

OAAI